Agree, those are questions we need to understand the answers to, and I would guess that's the next focus area: how to improve the initial series of vaccinations using this bivalent vaccine, or maybe a later a more-multi-valent vaccine. My guess is that right now, it's a matter of doing what needs to be done now to cover the majority of people, since we can't do it all at once.